Microbiology

Olivanic acid is a β-lactam antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antimicrobial activity against both Gram-positive and Gram-negative bacteria by inhibiting β-lactamase enzymes. This makes it a valuable compound for research applications in antibiotic resistance studies and the development of novel antimicrobial therapies.

Macquarimicin C is a potent antibiotic that targets bacterial ribosomal function. It exhibits significant antibacterial activity against a range of Gram-positive and Gram-negative pathogens. This compound is valuable for research applications related to antimicrobial resistance and the study of ribosome-inhibiting antibiotics.

Obafluorin is a β-Lactone Antibiotic known for its potent antibacterial activity against a variety of Gram-positive and Gram-negative bacteria. This compound, originally produced by Pseudomonas fluorescens ATCC 39502, effectively inhibits E. coli threonyl-tRNA synthetase, making it a valuable tool for research in microbiology and antibiotic development. Its unique mechanism of action underscores its potential in studying bacterial resistance and antibiotic efficacy.

Leucinostatin H is a polypeptide antibiotic derived from Paecilomyces marquandii, featuring a tertiary amine-oxide terminal group. It demonstrates potent inhibitory activity against Gram-positive bacteria, including Bacillus subtilis, B. cereus, and Staphylococcus aureus, with minimum inhibitory concentrations ranging from 10 to 100 μg/mL. Leucinostatin H is valuable for research applications in anti-infective therapies and plant disease management.

8"-Hydroxypactamycin is an antibiotic derived from Streptomyces SIPI-A-3-0121, primarily targeting bacterial protein synthesis. It exhibits potent antibacterial activity, making it a valuable tool for investigating bacterial resistance mechanisms and developing new antimicrobial strategies. Its unique structure and mechanism of action present opportunities for research in antibiotic efficacy and therapeutic applications.

Mycinamicin IV is an ester peptide antibiotic that targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable tool in the study of bacterial infection mechanisms and the development of new antimicrobial compounds. Mycinamicin IV is instrumental in research applications focused on antibiotic resistance and microbial pathogenesis.

Clavamycin E is a clavam antibiotic that targets bacterial cell wall synthesis. It exhibits potent antimicrobial activity against a range of Gram-positive bacteria, making it a valuable tool in studying bacterial resistance mechanisms. This compound is utilized in research applications focused on antibiotic development and the exploration of novel therapeutic strategies against resistant strains.

BK-218 is an orally active cephalosporin antibiotic that targets penicillin-binding proteins (PBPs). It demonstrates a potent inhibitory effect, surpassing that of Cephalexin and Cefoxitin, while exhibiting antibacterial activity comparable to Cefamandole. BK-218 is a valuable compound in the development of novel antibacterial therapies.

TAN-1057C is a potent antibiotic that targets bacterial cell wall synthesis, demonstrating remarkable antibacterial activity against both Gram-negative and Gram-positive bacteria. Notably, TAN-1057C effectively combats Methicillin-resistant Staphylococcus aureus, making it a valuable tool in research focusing on antibiotic resistance and bacterial infections. This compound is essential for studies exploring new therapeutic strategies and mechanisms of action against resistant bacterial strains.

Nortopixantrone is a 9-aza-anthrapyrazole-based antineoplastic antibiotic that targets tumor cell proliferation. It exhibits potent cytotoxic activity against various cancer types, making it a valuable tool in oncological research. Nortopixantrone is utilized in studies to explore mechanisms of action related to DNA intercalation and topoisomerase inhibition, contributing to advancements in cancer therapeutics.

Hydroxynybomycin is an antibiotic that targets and inhibits the growth of Gram-negative bacteria. This compound exhibits significant antibacterial activity, making it a valuable tool in research applications aimed at understanding bacterial resistance mechanisms and developing new antimicrobial therapies. Hydroxynybomycin's efficacy against a range of pathogenic strains positions it as a critical reagent for studies in microbiology and infectious disease research.

Pyrrolomycin D is a member of the pyrrolomycin class of antibiotics, derived from Actinosporangium species. It exhibits potent antibacterial activity against a range of Gram-positive bacteria through its inhibition of protein synthesis. This compound is of significant interest in microbiological research and antibiotic development studies, providing valuable insights into the mechanisms of antibiotic resistance and the potential for new therapeutic agents.

Leucomycin V is a macrolide antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. It exhibits strong antibacterial activity against Gram-positive bacteria and demonstrates efficacy against spirochetes, Rickettsia, and Chlamydia species. This compound is primarily utilized in microbiological research to investigate bacterial resistance mechanisms and the development of new therapeutic strategies.

Aspiculamycin is a nucleoside-derived antibiotic exhibiting a broad spectrum of antibacterial activity. It targets bacterial ribosomal protein synthesis, disrupting essential cellular processes. This compound is utilized in research to investigate bacterial resistance mechanisms and the efficacy of antimicrobial agents. Its unique mode of action makes it a valuable tool in the study of bacterial pathogens and the development of new antibiotics.

1-Hydroxysulfurmycin B is an anthracycline antibiotic that targets bacterial cell functions. It exhibits notable antibacterial activity against Gram-positive bacteria and demonstrates anti-tumor effects in various cancer cell lines. This compound is useful in research applications investigating antibiotic resistance and cancer therapeutics.

Altromycin E is an antibiotic that primarily targets bacterial pathogens, demonstrating significant antibacterial activity against Streptococci and Staphylococci with a minimum inhibitory concentration (MIC) ranging from 0.2 to 3.12 μg/mL. Additionally, its properties make it a valuable compound for anti-tumor research applications.

Chuangxinmycin is an antibiotic derived from Actinoplanes tsinanensis CPCC 200056, targeting bacterial infections. It demonstrates significant antibacterial activity in both in vitro and in vivo systems, making it a valuable tool for research on infections and antibiotic efficacy. Researchers can employ Chuangxinmycin to explore mechanisms of action and resistance in bacterial pathogens.

CF3–K11 is a stable antibiotic that targets bacterial growth. It exhibits potent antibacterial activity against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA). This compound is suitable for research applications focused on antibiotic resistance and the development of novel therapeutic strategies.

Arizonin A1 is an antibiotic that specifically targets Gram-positive bacteria. This microbial metabolite demonstrates potent antibacterial activity, making it a valuable tool for research in microbiology and antibiotic drug development. Its effectiveness against Gram-positive pathogens positions Arizonin A1 as an important compound for studies focused on bacterial resistance and therapeutic interventions.

3-O-Demethylmonensin B is a polyether antibiotic that targets a range of Gram-positive bacteria. This compound is derived from Streptomyces cinnamonensis LO-63 and exhibits potent antimicrobial activity. It is primarily utilized in microbiological studies and antibiotic research to explore its effects and mechanisms of action against resistant bacterial strains.

Endophenazine C is a phenazine antibiotic that functions by inhibiting bacterial DNA synthesis. It demonstrates potent antimicrobial activity against a range of Gram-positive and Gram-negative bacteria. This compound is primarily utilized in microbiological research to investigate bacterial resistance mechanisms and the development of novel antimicrobial agents.

Pluracidomycin B is a carbapenem antibiotic that targets bacterial cell wall synthesis. It exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria and is capable of inhibiting β-lactamase enzymes. This compound is valuable in microbiological research for investigating antibiotic resistance and evaluating bacterial susceptibility.

Gentamicin X2 is a minor aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits potent antibacterial activity against a broad spectrum of Gram-negative and some Gram-positive bacteria. Gentamicin X2 is commonly utilized in microbiology research to study bacterial resistance mechanisms and to evaluate antibiotic efficacy in various therapeutic contexts.

Demethylolivomycin A is an antitumor antibiotic that primarily targets cancer cells through its ability to interfere with DNA synthesis. It exhibits significant activity against Gram-positive bacteria and demonstrates efficacy against leukemia cell lines, including P388. This compound is valuable for research focused on developing new chemotherapeutic agents and exploring antibiotic mechanisms.

Hydroxymycotrienin A is an Ansa antibiotic that targets tumor cells by inhibiting their proliferation. It demonstrates potent antitumor activity, particularly against human neck tumor cell lines, showing enhanced efficacy against human papillomavirus (HPV) gene-positive cells such as HeLa, CaSKi, and SiHa, compared to HPV gene-negative counterparts. This compound is valuable for research in cancer therapeutics and the study of HPV-related oncogenesis.

Ceforanide (lysine) is a second-generation cephalosporin that functions as a bacterial inhibitor by interfering with bacterial cell wall synthesis. It exhibits a broad spectrum of in vitro antibacterial activity against various Gram-positive and Gram-negative bacteria. Ceforanide is primarily utilized in microbiological research to study bacterial resistance and the effects of cephalosporins on different bacterial strains.

10-Decarbomethoxyaclacinomycin A is an anthracycline antibiotic that functions through the inhibition of nucleic acid synthesis. Produced by the Streptomyces galilaeus MA144-Mlt mutant strain KE303, this compound exhibits notable antibacterial activities. It is valuable for research applications focused on understanding antibacterial mechanisms and exploring potential therapeutic interventions for bacterial infections.

RPR 102341 is an antibiotic that demonstrates structural similarity to the fluoroquinolone class. It exhibits significant antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV, leading to disruption of DNA replication and transcription. This compound is primarily utilized in research applications focused on antibiotic resistance mechanisms and the development of novel antimicrobial agents.

Sannamycin L is an aminoglycoside antibiotic that targets bacterial protein synthesis. It exhibits weak antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a subject of interest for studying bacterial resistance mechanisms and antibiotic efficacy. This compound can be utilized in research applications focused on the development of new antimicrobial agents.

2-Hydroxy-5-iminoazacyclopent-3-ene is a pyrroline antibiotic that targets bacterial cell wall synthesis. This compound exhibits moderate antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool for investigating antibiotic resistance mechanisms. Research applications include studying bacterial susceptibility and the development of new antibiotic therapies.

Pyralomicin 1b is an antibiotic known for its antibacterial activity. It acts by inhibiting bacterial protein synthesis, making it effective against a range of Gram-positive pathogens. This compound is valuable for research focused on bacterial resistance mechanisms and the development of new antimicrobial agents.

Chitotriose is a chitooligosaccharide derived from chitosan obtained from crab shells. It exhibits antibacterial activity specifically against Salmonella species. This compound is valuable for research applications in studying antimicrobial mechanisms and the development of antibacterial agents.

44-Homooligomycin A is an antitumor antibiotic that primarily targets fungal pathogens, demonstrating notable activity against species such as Aspergillus, Penicillium, and Fusarium. This compound shows limited efficacy against yeast and bacteria. In preclinical studies, 44-Homooligomycin A exhibits moderate antitumor activity against the Colon 26 cell line in vivo, making it a candidate for further investigation in cancer research and antifungal therapeutics.

Pyloricidin B is an antibiotic that specifically targets Helicobacter pylori. It exhibits significant antibacterial activity against this pathogen, making it a valuable tool for research related to gastric infections and related conditions. Pyloricidin B demonstrates selectivity, showing no activity against other bacterial species or yeast, highlighting its potential utility in studying H. pylori-related diseases.

4-O-Demethyl-11-deoxydoxorubicin is an anthracycline antibiotic that primarily targets DNA, resulting in the inhibition of topoisomerase II activity. It exhibits significant cytotoxicity against various cancer cell lines, including HeLa cells. This compound is utilized in research focusing on anti-cancer mechanisms and the development of novel therapeutic strategies.

Seitomycin is an anthraquinone antibiotic that primarily targets bacterial cells. It exhibits moderate antimicrobial activity against a range of Gram-positive bacteria, including Staphylococcus aureus and Bacillus subtilis, as well as Gram-negative bacteria such as Escherichia coli and Streptomyces chlorophyllus. This compound is relevant for research applications focusing on antibiotic susceptibility, bacterial resistance mechanisms, and the development of new antimicrobial agents.

Nebramycin V' is a multi-component aminoglycoside antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. It exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria, as well as mycobacteria. This makes it valuable for research applications related to antimicrobial resistance, bacterial infections, and the study of protein synthesis mechanisms.

Noboritomycins A is a polyether antibiotic that primarily targets Gram-positive bacteria. It exhibits antimicrobial activity, making it a valuable compound in the study of bacterial infections. Additionally, Noboritomycins A demonstrates weak anti-coccidial effects, which may be of interest in research related to parasitic diseases.

4-Hydroxyphlebiarubrone is a quinone antibiotic that exhibits activity against certain bacterial strains. It demonstrates weak resistance to Gram-negative bacteria, making it of interest in studies related to antibiotic resistance mechanisms. Additionally, its cytotoxic properties warrant further investigation in cellular biology and cancer research applications.

Armentomycin is a non-protein amino acid with potent antibiotic properties, primarily targeting Gram-negative bacteria. Its mechanism of action involves inhibition of bacterial growth, making it a valuable reagent for research focused on antibiotic efficacy and resistance mechanisms. Armentomycin serves as a critical tool for studies investigating microbial infections and developing novel antimicrobial strategies.

Parvodicin C3 is a glycopeptide antibiotic that exerts its antimicrobial activity by inhibiting bacterial cell wall synthesis. It demonstrates potent activity against various gram-positive pathogens, including Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. This compound is valuable for research applications focused on bacterial resistance mechanisms and the development of new antibacterial agents.

4-Hydroxybaumycinol A1 is an anthracycline antibiotic that exerts its primary mechanism through DNA intercalation, leading to the inhibition of topoisomerase II. This compound demonstrates significant antitumor activity, making it a valuable reagent for cancer research. Its potent effects on tumor cell proliferation position it as a useful tool in studies aimed at understanding and developing new cancer therapies.

Antibacterial agent 266 is an antibiotic that targets bacterial integrity, effectively inhibiting plant pathogens. It demonstrates notable activity with EC50 values of 24.1 μg/mL against Xanthomonas oryzae pv oryzae and 39.0 μg/mL against Xanthomonas axonopodis pv citri. This reagent is valuable for research in plant pathology and the development of agricultural antimicrobial agents.

Maridomycin II is a macrolide antibiotic that targets bacterial protein synthesis. It exhibits potent activity against Gram-positive bacteria and mycoplasma, making it a valuable tool for studying bacterial infections. Additionally, Maridomycin II has demonstrated protective effects in murine models of Gram-positive bacterial infections, highlighting its potential utility in infectious disease research.

Milbemycin α14 is an antibiotic that exerts its effects by effectively targeting and eliminating nematodes and mites. This compound is commonly used in research applications focusing on parasitic infections and pest control, providing a valuable tool for biologists studying the mechanisms of action of antiparasitic agents.

Fluvirucin A2 is an antibiotic specifically targeting the influenza A virus. It demonstrates potent antiviral activity, disrupting viral replication and reducing infection severity. This compound is valuable for research applications investigating antiviral strategies and the mechanisms of influenza pathogenesis.

Halymecin A is an antibiotic derived from marine microbes, primarily targeting bacterial and fungal pathogens. Although it exhibits only weak antibacterial and antifungal activity, it serves as a valuable tool for studies in microbial interactions and the exploration of novel antibacterial compounds. This compound's unique origin and modest bioactivity make it relevant for research in natural product chemistry and antibiotic development.

Atramycin A is an isotetracenone-based antitumor antibiotic that exhibits potent cytotoxic activity against various cancer cell lines. Its mechanism involves DNA intercalation and the inhibition of topoisomerase II, leading to disruptions in DNA replication and cellular proliferation. Atramycin A is valuable for research applications focused on cancer biology and the development of new antitumor therapies.

Cystothiazole B is a bithiazole-type antibiotic that exhibits antimicrobial activity by inhibiting bacterial protein synthesis. It is primarily extracted from the organism Cystobacter fuscus. This compound is utilized in research applications focused on antibacterial mechanisms and the identification of novel antibiotics.

Deoxypheganomycin D is a specific antimycobacterial agent that demonstrates selective inhibition of Mycobacterium 607 growth without cross-resistance to other antibiotics. At a concentration of 28 μM, it significantly reduces bacterial proliferation while showing minimal impact on DNA, RNA, or protein synthesis pathways. Notably, at 7 μM, Deoxypheganomycin D interferes with leucine influx and alters efflux dynamics, suggesting its action may involve interactions with the cell membrane and distinct mycobacterial lipid components. This reagent is valuable for researchers studying mycobacterial resistance mechanisms and developing alternative treatment strategies.